HLA-DR2 (DR2) of the HLA-DR serotype system, is a broad antigen serotype that is now preferentially covered by HLA-DR15 and HLA-DR16 serotype group. This serotype primarily recognizes gene products of the HLA-DRB1*15 and HLA-DRB1*16 allele groups.
Contents |
| DRB1* | DR15 | DR2 | DR16 | Sample |
| allele | % | % | % | size (N) |
| 1501 | 76 | 23 | 6428 | |
| 1502 | 77 | 16 | 676 | |
| 1503 | 81 | 13 | 286 | |
| 1504 | >50 | 1 | ||
| 1505 | >25 | 2 | ||
| 1507 | >50 | 1 | ||
| . | ||||
| DR16 | DR2 | DR15 | N | |
| 1601 | 41 | 29 | 19 | 703 |
| 1602 | 47 | 30 | 16 | 239 |
| 1604 | >50 | 1 |
DR2 serotypes are associated with Goodpasture syndrome, multiple sclerosis[2], and narcolepsy, tuberculoid leprosy[3] (multi-drug resistant tuberculosis or leprosy),[4] Hashimoto's thyroiditis[5], ulcerative colitis(Japanese)[6], primary biliary cirrhosis and autoimmune hepatitis[7]. DR2 is also found in all patients that test positive for anti-anti-Asn-RNA-synthetaes and chronic interstitial lung disease.[8]
DR2 is linked to the HLA-DR53.
|
|||||||||||||||||
|
|